Candida albicans and bacterial microbiota interactions in the cecum during recolonization following broad-spectrum antibiotic therapy

Infection and Immunity

Volumn 80, Issue 10, 2012, Pages 3371-3380

  Mason, Katie L ^a   Downward, John R Erb ^a   Mason, Kelly D ^a   Falkowski, Nicole R ^a   Eaton, Kathryn A ^a   Kao, John Y ^a   Young, Vincent B ^a   Huffnaglea, Gary B ^a  

^a UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CEFOPERAZONE;

ANIMAL EXPERIMENT; ANTIBIOTIC THERAPY; ARTICLE; BACTEROIDETES; CANDIDA ALBICANS; ENTEROCOCCUS FAECALIS; FEMALE; FUNGAL COLONIZATION; HISTOLOGY; INTESTINE FLORA; LACTOBACILLUS; MICROBIOME; MOUSE; NONHUMAN; ORGANISMAL INTERACTION; PRIORITY JOURNAL;

ANIMALS; ANTI-BACTERIAL AGENTS; BACTERIA; BACTEROIDETES; CANDIDA ALBICANS; CECUM; CEFOPERAZONE; FEMALE; GERM-FREE LIFE; INFLAMMATION; LACTOBACILLUS; METAGENOME; MICE; MICE, INBRED C57BL; POLYMORPHISM, RESTRICTION FRAGMENT LENGTH;

EID: 84867588283     PISSN: 00199567     EISSN: 10985522     Source Type: Journal    
DOI: 10.1128/IAI.00449-12     Document Type: Article

References (36)

1. Antonopoulos DA, et al. 2009. Reproducible community dynamics of the gastrointestinal microbiota following antibiotic perturbation. Infect. Immun. 77:2367-2375.
2. Artwohl J, McCLain A, Cera L. 1988. Population changes of indigenous murine Candida pintolopesii under various experimental conditions and routes of inoculation. Appl. Environ. Microbiol. 54:2371-2374.
3. Brandl K, et al. 2008. Vancomycin-resistant enterococci exploit antibiotic-induced innate immune deficits. Nature 455:804-807.
4. Cash HL, Whitham CV, Behrendt CL, Hooper LV. 2006. Symbiotic bacteria direct expression of an intestinal bactericidal lectin. Science 313: 1126-1130.
5. Franz CM, Holzapfel WH, Stiles ME. 1999. Enterococci at the crossroads of food safety? Int. J. Food Microbiol. 47:1-24.
6. Hummel RP, Oestreicher EJ, Maley MP, Macmillan BG. 1973. Inhibition of Candida albicans by Escherichia coli in vitro and in the germfree mouse. J. Surg. Res. 15:53-58.
7. Kennedy MJ. 1981. Inhibition of Candida albicans by the anaerobic oral flora of mice in vitro. Sabouraudia 19:205-208.
8. Kennedy MJ, Volz PA. 1985. Ecology of Candida albicans gut colonization: inhibition of Candida adhesion, colonization, and dissemination from the gastrointestinal tract by bacterial antagonism. Infect. Immun. 49:654-663.
9. Kennedy MJ, Volz PA. 1985. Effect of various antibiotics on gastrointestinal colonization and dissemination by Candida albicans. Sabouraudia 23:265-273.
10. Koh AY, Kohler JR, Coggshall KT, Van Rooijen N, Pier GB. 2008. Mucosal damage and neutropenia are required for Candida albicans dissemination. PLoS Pathog. 4:e35. doi:10.1371/journal.ppat.0040035.
11. Kuehl CJ, Wood HD, Marsh TL, Schmidt TM, Young VB. 2005. Colonization of the cecal mucosa by Helicobacter hepaticus impacts the diversity of the indigenous microbiota. Infect. Immun. 73:6952-6961.
12. Ley RE, et al. 2005. Obesity alters gut microbial ecology. Proc. Natl. Acad. Sci. U. S. A. 102:11070 -11075.
13. Mason KL, et al. 2012. Interplay between the gastric bacterial microbiota and Candida albicans during postantibiotic recolonization and gastritis. Infect. Immun. 80:150 -158.
14. Morales DK, Hogan DA. 2010. Candida albicans interactions with bacteria in the context of human health and disease. PLoS Pathog. 6:e1000886. doi:10.1371/journal.ppat.1000886.
15. Nagalingam NA, Kao JY, Young VB. 2011. Microbial ecology of the murine gut associated with the development of dextran sodium sulfateinduced colitis. Inflamm. Bowel Dis. 17:917-926.
16. Nagalingam NA, Lynch SV. 2012. Role of the microbiota in inflammatory bowel diseases. Inflamm. Bowel Dis. 18:968 -984.
17. Naglik Jr, Fidel PL, Jr, Odds FC. 2008. Animals models of mucosal Candida infection. FEMS Microbiol. Lett. 283:129 -139.
18. Nakajo K, et al. 2006. Resistance to acidic and alkaline environments in the endodontic pathogen Enterococcus faecalis. Oral Microbiol. Immunol. 21:283-288.
19. Nobile CJ, Mitchell AP. 2005. Regulation of cell-surface genes and biofilm formation by the C. albicans transcription factor Bcr1p. Curr. Biol. 15:1150 -1155.
20. Noverr MC, Falkowski NR, McDonald RA, McKenzie AN, Huffnagle GB. 2005. Development of allergic airway disease in mice following antibiotic therapy and fungal microbiota increase: role of host genetics, antigen, and interleukin-13. Infect. Immun. 73:30 -38.
21. Noverr MC, Huffnagle GB. 2004. Regulation of Candida albicans morphogenesis by fatty acid metabolites. Infect. Immun. 72:6206-6210.
22. Noverr MC, Noggle RM, Toews GB, Huffnagle GB. 2004. Role of antibiotics and fungal microbiota in driving pulmonary allergic responses. Infect. Immun. 72:4996 -5003.
23. Paster BJ, et al. 2001. Bacterial diversity in human subgingival plaque. J. Bacteriol. 183:3770 -3783.
24. Rahman D, Mistry M, Thavaraj S, Challacombe SJ, Naglik JR. 2007. Murine model of concurrent oral and vaginal Candida albicans colonization to study epithelial host-pathogen interactions. Microbes Infect. 9:615- 622.
25. Rosenbach A, Dignard D, Pierce JV, Whiteway M, Kumamoto CA. 2010. Adaptations of Candida albicans for growth in the mammalian intestinal tract. Eukaryot. Cell 9:1075-1086.
26. Ruiz-Sanchez D, Calderon-Romero L, Sanchez-Vega JT, Tay J. 2002. Intestinal candidiasis. A clinical report and comments about this opportunistic pathology. Mycopathologia 156:9 -11.
27. Russell C, Lay KM. 1973. Natural history of Candida species and yeasts in the oral cavities of infants. Arch. Oral Biol. 18:957-962.
28. Samonis G, Anaissie EJ, Bodey GP. 1990. Effects of broad-spectrum antimicrobial agents on yeast colonization of the gastrointestinal tracts of mice. Antimicrob. Agents Chemother. 34:2420 -2422.
29. Savage DC. 1969. Microbial interference between indigenous yeast and lactobacilli in the rodent stomach. J. Bacteriol. 98:1278 -1283.
30. Schloss PD, et al. 2009. Introducing mothur: open-source, platformindependent, community-supported software for describing and comparing microbial communities. Appl. Environ. Microbiol. 75:7537-7541.
31. Taylor BN, Jr, et al. 2000. In vivo virulence of Candida albicans isolates causing mucosal infections in people infected with the human immunodeficiency virus. J. Infect. Dis. 182:955-959.
32. van der Waaij D. 1987. Colonization resistance of the digestive tract-mechanism and clinical consequences. Nahrung 31:507-517.
33. van der Waaij D, Berghuis JM. 1974. Determination of the colonization resistance of the digestive tract of individual mice. J. Hyg. 72:379 -387.
34. Van der Waaij D, Van der Waaij BD. 1990. The colonization resistance of the digestive tract in different animal species and in man; a comparative study. Epidemiol. Infect. 105:237-243.
35. Wagner RD, et al. 2000. Probiotic effects of feeding heat-killed Lactobacillus acidophilus and Lactobacillus casei to Candida albicans-colonized immunodeficient mice. J. Food Prot. 63:638-644.
36. White SJ, et al. 2007. Self-regulation of Candida albicans population size during GI colonization. PLoS Pathog. 3:e184. doi:10.1371/journal.ppat.0030184.